FIGURE 4.
Individual plasma concentration‐time curves of (a) remdesivir and (b) GS‐441524 (right) after intravenous infusion of 100 mg remdesivir at steady state in patients with impaired renal function undergoing intermittent hemodialysis
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.